NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates ("Broadwood†or "we†), which together own 30.2% of the outstanding common stock of STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA), today responded to the fourth postponement of STAAR's Special Meeting of Shareholders (the "Special Meeting†) in connection with the proposed acquisition of STAAR by Alcon Inc. ("Alcon†) (NYSE: ALC). The Special Meeting, which was originally scheduled to be held on October 23, 2. ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to require STAAR to adjourn its Special Meeting of Stockholders in connection with the Alcon merger agreement (the "Special Meeting†). As a result, the Special Meeting, which was scheduled for December 19, 2025 at 8:30 a.m. Pacific Time, has been adjourned to January 6, 2026 ...

As I write this, it is the middle of December, and the Alcon Inc. ( ALC ) acquisition of LENSAR, INC. ( LNSR ) remains unfinished, despite the two firms earlier hoping to complete it by the endRobert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options, mainly covered calls and collars with long stocks. He is a freelance writer, and his projects include a website that provides information for new and intermediate-level mutual fund investors. A resident of Airdrie, Alberta ...

Expresses Disappointment in the Board's and Management's Continued Pursuit of Ill-advised Deal CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement reiterating its intention to vote AGAINST the Company's proposed sale to Alcon Inc. ("Alcon") (NYSE: ALC) and expressing its disappoi ...

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood†) today issued the following letter to the Board of Directors (the "Board†) of STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA). Broadwood, which owns 30.2% of STAAR's outstanding common stock, continues to urge its fellow shareholders to vote "AGAINST†the proposed acquisition of STAAR by Alcon Inc. ("Alcon†) (NYSE: ALC). Shareholders can find additional information at www.LetSTAARS. ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following open letter to STAAR stockholders: Dear STAAR Surgical Stockholders: The Special Meeting of Stockholders to vote on the amended agreement with Alcon Inc. (SIX/NYSE: ALC) is just days away. How you vote at the Special Meeting will greatly influence the value of your shares. Yo. ...

® LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICLâ"¢) for vision correction, today reported that independent industry analysts have recognized the value provided to STAAR stockholders by the Company's amended merger agreement with Alcon (SIX/NYSE: ALC) and the merits of the Alcon transaction. The Alcon merger agreement, as revised on December 9, 2025, provides that STAAR stockholders wil ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) ("STAAR†), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ"¢) for vision correction, today announced that leading independent proxy advisory firm Institutional Shareholder Services ("ISS†) has issued a new report and revised its recommendation with respect to STAAR's merger with Alcon. ISS is now recommending that all STAAR stockholders vote "FOR†STAAR's amended merger agree. ...

代理咨询公司Glass Lewis的建议 - 领先的独立代理咨询公司Glass Lewis & Co LLC重申其建议 即STAAR Surgical Company的股东应对Alcon Inc提出的收购案投反对票 [1] - Glass Lewis在其报告中得出结论 认为不存在有说服力的理由支持该交易 [1] STAAR Surgical公司的收购动态 - STAAR Surgical Company是纳斯达克上市公司 股票代码为STAA 其正面临被Alcon Inc收购的提案 Alcon Inc是纽约证券交易所上市公司 股票代码为ALC [1] - 股东维权投资机构Broadwood Partners L P及其关联方宣布了Glass Lewis的上述建议 [1]

评级与目标价调整 - 美银证券将爱尔康公司评级从“买入”下调至“表现不佳”，并将其目标价从100美元大幅下调至75美元 [1] 下调原因与市场环境 - 下调评级基于对前景的悲观看法，原因包括市场疲软、竞争加剧以及公司多次下调业绩指引打击了市场情绪 [1] - 尽管部分投资者预期信心将在2026年改善，但市场共识预测显得过于乐观，其假设了急剧反弹、市场份额增长以及Unity产品的激进增长，然而这些前景的可预见性有限 [2] 财务预测与估值分析 - 美银证券对该公司2026财年和2027财年的每股收益预测分别比市场共识低4%和7% [2] - 公司警告称其利润率也存在下行风险 [2] - 即使股价已从2024年高点回调20%，爱尔康约25倍的远期市盈率相对于其2025年至2027年预计低于10%的每股收益复合年增长率而言仍然偏高 [3] - 美银证券将2026财年每股收益预测下调了8%，并基于更高的加权平均资本成本假设和市场环境带来的阻力，调低了其估值倍数 [3]